Literature DB >> 690092

Caffeine and schizophrenia.

E J Mikkelsen.   

Abstract

Two cases are described in which markedly increased consumption of caffeine led to an exacerbation of a schizophrenic process. The original description of this phenomenon and the clinical and basic science literature regarding the psychotropic effects of caffeine are reviewed. The cases are discussed in light of the clinical and research implications.

Entities:  

Mesh：

Substances：

Year:  1978        PMID： 690092

Source DB:  PubMed          Journal:  J Clin Psychiatry        ISSN： 0160-6689            Impact factor:   4.384


  19 in total

1.  Possible mechanism of interaction of GABAergic-adenosinergic systems in the regulation of theophylline-induced locomotor activity under its nontolerant and tolerant conditions.

Authors:  M Mandal; M K Poddar
Journal:  Neurochem Res       Date:  1999-06       Impact factor: 3.996

Review 2.  Drug interactions between herbal and prescription medicines.

Authors:  Elizabeth M Williamson
Journal:  Drug Saf       Date:  2003       Impact factor: 5.606

3.  Effects of chronic caffeine exposure during adolescence and subsequent acute caffeine challenge during adulthood on rat brain serotonergic systems.

Authors:  M R Arnold; P H Williams; J A McArthur; A R Archuleta; C E O'Neill; J E Hassell; D G Smith; R K Bachtell; C A Lowry
Journal:  Neuropharmacology       Date:  2018-12-20       Impact factor: 5.250

Review 4.  Caffeine Use Disorder: A Comprehensive Review and Research Agenda.

Authors:  Steven E Meredith; Laura M Juliano; John R Hughes; Roland R Griffiths
Journal:  J Caffeine Res       Date:  2013-09

5.  Schizophrenia: Nutrition and Alternative Treatment Approaches.

Authors:  Berenice Royal
Journal:  Schizophr Bull       Date:  2015-01-22       Impact factor: 9.306

Review 6.  Caffeine and health.

Authors:  C H Ashton
Journal:  Br Med J (Clin Res Ed)       Date:  1987-11-21

7.  Upregulation of adenosine A2A receptors induced by atypical antipsychotics and its correlation with sensory gating in schizophrenia patients.

Authors:  Jie Zhang; Chadi G Abdallah; Junqing Wang; Xiaona Wan; Chunlian Liang; Liyun Jiang; Yuzhen Liu; Haixing Huang; Xiaohong Hong; Qingjun Huang; Renhua Wu; Chongtao Xu
Journal:  Psychiatry Res       Date:  2012-06-16       Impact factor: 3.222

8.  Systemic administration of the adenosine A(2A) agonist CGS 21680 induces sedation at doses that suppress lever pressing and food intake.

Authors:  Susana Mingote; Mariana Pereira; Andrew M Farrar; Peter J McLaughlin; John D Salamone
Journal:  Pharmacol Biochem Behav       Date:  2008-01-17       Impact factor: 3.533

9.  Adenosine A(2A) receptors in psychopharmacology: modulators of behavior, mood and cognition.

Authors:  Hai-Ying Shen; Jiang-Fan Chen
Journal:  Curr Neuropharmacol       Date:  2009-09       Impact factor: 7.363

10.  Interaction of chlorpromazine with tea and coffee.

Authors:  H J Cheeseman; M J Neal
Journal:  Br J Clin Pharmacol       Date:  1981-08       Impact factor: 4.335
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.